š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
A multi-centre, randomized, placebo controlled, trial. Participants at high...
Status
Completed
Location
Maputo Central Hospital
Start Date
2015-04
Trial ID
NCT01945268
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Status
Completed
Location
CenExel CNS- Site Number : 8400005
Start Date
2024-11-04
Trial ID
NCT06641180
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691339
Hypothesis 1: The safety profile in adult allogeneic stem cell hematopoieti...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center, Clinical Trials Information Program
Start Date
2010-10
Trial ID
NCT01215734
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01430819
The aim of the study is to generate data on key parameters associated with ...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01258595
Treatments Being Tested
The goal of this clinical research study is to learn if lenalidomide can in...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2014-11-24
Trial ID
NCT01924169
Treatments Being Tested
This randomized phase II studies the side effects of high-dose trivalent in...
Status
Completed
Location
University of Alabama
Start Date
2017-10-09
Trial ID
NCT03179761
The body's immune system (fights infection) is known to decline during the ...
Status
Completed
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Start Date
2005-04-25
Trial ID
NCT00170482